Pacific Biosciences of California, Inc. Increase (Decrease) in Contract with Customer, Liability
Pacific Biosciences of California, Inc. (PACB) reported Increase (Decrease) in Contract with Customer, Liability of -$423.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInContractWithCustomerLiability · last filed 2026-08-06
- Pacific Biosciences of California, Inc. increase (decrease) in contract with customer, liability for the quarter ending 2026-06-30 was -$442.00K.
- Pacific Biosciences of California, Inc. increase (decrease) in contract with customer, liability for the quarter ending 2026-03-31 was $19.00K, a 98.57% decline year-over-year.
- Pacific Biosciences of California, Inc. increase (decrease) in contract with customer, liability for the quarter ending 2025-12-31 was -$584.00K.
- Pacific Biosciences of California, Inc. increase (decrease) in contract with customer, liability for the quarter ending 2025-09-30 was -$123.00K.
- Pacific Biosciences of California, Inc. increase (decrease) in contract with customer, liability for fiscal 2025 was $101.00K.
- Pacific Biosciences of California, Inc. increase (decrease) in contract with customer, liability for fiscal 2024 was -$2.11M.
- Pacific Biosciences of California, Inc. increase (decrease) in contract with customer, liability for fiscal 2023 was -$10.42M.
- Pacific Biosciences of California, Inc. increase (decrease) in contract with customer, liability for fiscal 2022 was -$3.73M.
| Period end | Increase (Decrease) in Contract with Customer, Liability 3 month | Increase (Decrease) in Contract with Customer, Liability 6 month | Increase (Decrease) in Contract with Customer, Liability 9 month | Increase (Decrease) in Contract with Customer, Liability 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$442.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$423.00K 10-Q · filed 2026-08-06 | -$1.01M derived: sum of 3 quarters · filed 2026-08-06 | -$1.13M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $19.00K 10-Q · filed 2026-05-08 | -$565.00K derived: sum of 2 quarters · filed 2026-05-08 | -$688.00K derived: sum of 3 quarters · filed 2026-05-08 | -$1.21M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | -$584.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$707.00K derived: sum of 2 quarters · filed 2026-02-25 | -$1.23M derived: sum of 3 quarters · filed 2026-08-06 | $101.00K 10-K · filed 2026-02-25 |
| 2025-09-30 | -$123.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$647.00K derived: sum of 2 quarters · filed 2026-08-06 | $685.00K 10-Q · filed 2025-11-06 | -$2.30M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | -$524.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $808.00K 10-Q · filed 2026-08-06 | -$2.17M derived: sum of 3 quarters · filed 2026-08-06 | -$4.35M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $1.33M 10-Q · filed 2026-05-08 | -$1.65M derived: sum of 2 quarters · filed 2026-05-08 | -$3.82M derived: sum of 3 quarters · filed 2026-05-08 | -$2.38M derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | -$2.98M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$5.15M derived: sum of 2 quarters · filed 2026-02-25 | -$3.71M derived: sum of 3 quarters · filed 2026-02-25 | -$2.11M 10-K · filed 2026-02-25 |
| 2024-09-30 | -$2.17M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$726.00K derived: sum of 2 quarters · filed 2025-11-06 | $875.00K 10-Q · filed 2025-11-06 | -$4.68M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-06-30 | $1.45M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $3.05M 10-Q · filed 2025-08-07 | -$2.51M derived: sum of 3 quarters · filed 2026-02-25 | -$5.06M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-03-31 | $1.60M 10-Q · filed 2025-05-12 | -$3.95M derived: sum of 2 quarters · filed 2026-02-25 | -$6.50M derived: sum of 3 quarters · filed 2026-02-25 | -$9.24M derived: sum of 4 quarters · filed 2026-02-25 |
| 2023-12-31 | -$5.55M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$8.10M derived: sum of 2 quarters · filed 2026-02-25 | -$10.84M derived: sum of 3 quarters · filed 2026-02-25 | -$10.42M 10-K · filed 2026-02-25 |
| 2023-09-30 | -$2.55M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$5.29M derived: sum of 2 quarters · filed 2024-11-12 | -$4.87M 10-Q · filed 2024-11-12 | -$5.03M derived: sum of 4 quarters · filed 2025-03-17 |
| 2023-06-30 | -$2.74M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | -$2.32M 10-Q · filed 2024-08-09 | -$2.48M derived: sum of 3 quarters · filed 2025-03-17 | -$3.94M derived: sum of 4 quarters · filed 2025-03-17 |
| 2023-03-31 | $423.00K 10-Q · filed 2024-05-09 | $264.00K derived: sum of 2 quarters · filed 2025-03-17 | -$1.20M derived: sum of 3 quarters · filed 2025-03-17 | -$5.26M derived: sum of 4 quarters · filed 2025-03-17 |
| 2022-12-31 | -$159.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-17 | -$1.62M derived: sum of 2 quarters · filed 2025-03-17 | -$5.68M derived: sum of 3 quarters · filed 2025-03-17 | -$3.73M 10-K · filed 2025-03-17 |
| 2022-09-30 | -$1.46M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | -$5.52M derived: sum of 2 quarters · filed 2023-11-03 | -$3.58M 10-Q · filed 2023-11-03 | |
| 2022-06-30 | -$4.06M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | -$2.12M 10-Q · filed 2023-08-04 | ||
| 2022-03-31 | $1.95M 10-Q · filed 2023-05-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B |